93668-14-5

Usage

Uses

Used in Pharmaceutical Research:
3-(1H-imidazol-1-yl)-1-butanamine (SALTDATA: FREE) is used as a building block for the synthesis of various drugs, contributing to the development of new therapeutic agents.
Used in Drug Development:
3-(1H-imidazol-1-yl)-1-butanamine (SALTDATA: FREE) is used as a histamine H3 and H4 receptor agonist for the potential treatment of allergies, inflammation, and central nervous system disorders.
Used in Safety and Handling:
3-(1H-imidazol-1-yl)-1-butanamine (SALTDATA: FREE) is used as a chemical compound that requires careful handling and adherence to proper safety guidelines to minimize potential health hazards.

Upstream product

• 62093-11-2 3-imidazol-1-yl-butyronitrile 
• 288-32-4 1H-imidazole 
• 4786-20-3 crotononitrile 

Downstream Products

• 110552-74-4 2-Amino-5-chloro-N-(3-imidazol-1-yl-butyl)-benzamide 
• 110552-79-9 2-Amino-N-[3-(1H-imidazol-1-yl)butyl]-5-methylbenzamide 
• 100467-74-1 4-Bromo-N-(3-imidazol-1-yl-butyl)-benzamide 
• 100467-73-0 4-Chloro-N-(3-imidazol-1-yl-butyl)-benzamide 
• 100467-72-9 3-Chloro-N-(3-imidazol-1-yl-butyl)-benzamide 
• 100467-75-2 N-(3-Imidazol-1-yl-butyl)-4-trifluoromethyl-benzamide 

Relevant academic research and scientific papers

PIPERAZINE DERIVATIVES AS FARNESYL PROTEIN TRANSFERASE INHIBITORS

Disclosed are compounds of the formula: wherein R13 represents an imidazole ring; R14 represents a carbamate, urea, amide or sulfonamide group, and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.

N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions

This disclosure describes novel N-[ω-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.